Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (60)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Preckel, B.
Right arrow Articles by Thamer, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Preckel, B.
Right arrow Articles by Thamer, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, Vol 81, Issue 6 905-912, Copyright © 1998 by The Board of Management and Trustees of the British Journal of Anaesthesia

LABORATORY INVESTIGATIONS

Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo

B. Preckel, W. Schlack, T. Comfere, D. Obal, H. Barthel and V. Thamer
Institut fur Klinische Anaesthesiologie, Heinrich-Heine-Universitat Dusseldorf, Postfach 10 10 07, D-40001 Dusseldorf, Germany; Physiologisches Institut I, Heinrich-Heine-Universitat Dusseldorf, Postfach 10 10 07, D-40001 Dusseldorf, Germany

It is known that volatile anaesthetics protect myocardial tissue against ischaemic and reperfusion injury in vitro. In this investigation, we have determined the effects of the inhalation anaesthetics, enflurane, isoflurane, sevoflurane and desflurane, administered only during early reperfusion, on myocardial reperfusion injury in vivo. Fifty chloralose-anaesthetized rabbits were subjected to 30 min of occlusion of a major coronary artery followed by 120 min of reperfusion. Left ventricular pressure (LVP, tip-manometer), cardiac output (CO, ultrasonic flow probe) and infarct size (triphenyltetrazolium staining) were determined. During the first 15 min of reperfusion, five groups of 10 rabbits each received 1 MAC of enflurane (enflurane group), isoflurane (isoflurane group), sevoflurane (sevoflurane group) or desflurane (desflurane group), and 10 rabbits served as untreated controls (control group). Haemodynamic baseline values were similar between groups (mean LVP 106 (SEM 2) mm Hg; CO 281(7) ml min-1). During coronary occlusion, LVP and CO were reduced to the same extent in all groups (LVP 89% of baseline; CO 89%). Administration of inhalation anaesthetics during early reperfusion further reduced both variables, but they recovered after discontinuation of the anaesthetics to values not different from control animals. Infarct size was reduced from 49 (5)% of the area at risk in the control group to 32 (3)% in the desflurane group (P = 0.021), and to 36 (2)% in the sevoflurane group (P = 0.097). In the enflurane group, infarct size was 39 (5)% (P = 0.272). Isoflurane had no effect on infarct size (48 (5)%, P = 1.000). The results show that desflurane and sevoflurane markedly reduced infarct size and therefore can protect myocardium against reperfusion injury in vivo. Enflurane had only a marginal effect and isoflurane offered no protection against reperfusion injury in vivo. These different effects suggest different protective mechanisms at the cellular level.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
D. T. Andrews, A. G. Royse, and C. F. Royse
Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops
Br. J. Anaesth., November 1, 2009; 103(5): 654 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
J. Frassdorf, S. De Hert, and W. Schlack
Anaesthesia and myocardial ischaemia/reperfusion injury
Br. J. Anaesth., July 1, 2009; 103(1): 89 - 98.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
R. Huhn, A. Heinen, N. C. Weber, M. W. Hollmann, W. Schlack, and B. Preckel
Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore
Br. J. Anaesth., April 1, 2008; 100(4): 465 - 471.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
N. Bedirli, E. Ofluoglu, M. Kerem, G. Utebey, M. Alper, D. Yilmazer, A. Bedirli, O. Ozlu, and H. Pasaoglu
Hepatic Energy Metabolism and the Differential Protective Effects of Sevoflurane and Isoflurane Anesthesia in a Rat Hepatic Ischemia-Reperfusion Injury Model
Anesth. Analg., March 1, 2008; 106(3): 830 - 837.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
V. Piriou, J. Mantz, G. Goldfarb, M. Kitakaze, P. Chiari, S. Paquin, C. Cornu, J.-B. Lecharny, P. Aussage, E. Vicaut, et al.
Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial
Br. J. Anaesth., November 1, 2007; 99(5): 624 - 631.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
M. Meco, S. Cirri, C. Gallazzi, G. Magnani, and D. Cosseta
Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 319 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. Obal, K. Rascher, C. Favoccia, S. Dettwiler, and W. Schlack
Post-conditioning by a short administration of desflurane reduced renal reperfusion injury after differing of ischaemia times in rats
Br. J. Anaesth., December 1, 2006; 97(6): 783 - 791.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. Cromheecke, V. Pepermans, E. Hendrickx, S. Lorsomradee, P. W. ten Broecke, B. A. Stockman, I. E. Rodrigus, and S. G. De Hert
Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass.
Anesth. Analg., August 1, 2006; 103(2): 289 - 96, table of contents.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
O. Gateau-Roesch, L. Argaud, and M. Ovize
Mitochondrial permeability transition pore and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 264 - 273.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. Obal, S. Dettwiler, C. Favoccia, H. Scharbatke, B. Preckel, and W. Schlack
The Influence of Mitochondrial KATP-Channels in the Cardioprotection of Preconditioning and Postconditioning by Sevoflurane in the Rat In Vivo
Anesth. Analg., November 1, 2005; 101(5): 1252 - 1260.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
Y. Gozal, J. Raphael, J. Rivo, E. Berenshtein, M. Chevion, and B. Drenger
Isoflurane does not mimic ischaemic preconditioning in decreasing hydroxyl radical production in the rabbit
Br. J. Anaesth., October 1, 2005; 95(4): 442 - 447.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
Y. Kidani, T. Taniguchi, H. Kanakura, Y. Takemoto, K. Tsuda, and K. Yamamoto
Sevoflurane Pretreatment Inhibits Endotoxin-Induced Shock in Rats
Anesth. Analg., October 1, 2005; 101(4): 1152 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
S. G. De Hert, F. Turani, S. Mathur, and D. F. Stowe
Cardioprotection with Volatile Anesthetics: Mechanisms and Clinical Implications
Anesth. Analg., June 1, 2005; 100(6): 1584 - 1593.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
B. Bein, J. Renner, D. Caliebe, J. Scholz, A. Paris, S. Fraund, W. Zaehle, and P. H. Tonner
Sevoflurane but Not Propofol Preserves Myocardial Function During Minimally Invasive Direct Coronary Artery Bypass Surgery
Anesth. Analg., March 1, 2005; 100(3): 610 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. Zaugg, M. C. Schaub, and P. Foex
Myocardial injury and its prevention in the perioperative setting
Br. J. Anaesth., July 1, 2004; 93(1): 21 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
B. Haelewyn, L. Zhu, J. L. Hanouz, E. Persehaye, S. Roussel, P. Ducouret, and J. L. Gerard
Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium
Br. J. Anaesth., April 1, 2004; 92(4): 552 - 557.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Ghosh and M. Galinanes
Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 133 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
R. Serita, H. Morisaki, K. Ai, Y. Morita, Y. Innami, T. Satoh, S. Kosugi, Y. Kotake, and J. Takeda
Sevoflurane preconditions stunned myocardium in septic but not healthy isolated rat hearts
Br. J. Anaesth., December 1, 2002; 89(6): 896 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. Ebel, B. Preckel, A. You, J. Mullenheim, W. Schlack, and V. Thamer
Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia
Br. J. Anaesth., June 1, 2002; 88(6): 828 - 835.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
B. Pouzet, J.-B. Lecharny, M. Dehoux, S. Paquin, M. Kitakaze, J. Mantz, and P. Menasche
Is there a place for preconditioning during cardiac operations in humans?
Ann. Thorac. Surg., March 1, 2002; 73(3): 843 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
D. Obal, B. Preckel, H. Scharbatke, J. Mullenheim, F. Hoterkes, V. Thamer, and W. Schlack
One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo
Br. J. Anaesth., December 1, 2001; 87(6): 905 - 911.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Hara, S. Tomiyasu, C. Sungsam, M. Fukusaki, and K. Sumikawa
Sevoflurane Protects Stunned Myocardium Through Activation of Mitochondrial ATP-Sensitive Potassium Channels
Anesth. Analg., April 1, 2001; 92(5): 1139 - 1145.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
B. Preckel, J. Mullenheim, A. Moloschavij, V. Thamer, and W. Schlack
Xenon Administration During Early Reperfusion Reduces Infarct Size After Regional Ischemia in the Rabbit Heart In Vivo
Anesth. Analg., December 1, 2000; 91(6): 1327 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. F. Coetzee, P. J. le Roux, S. Genade, and A. Lochner
Reduction of Postischemic Contractile Dysfunction of the Isolated Rat Heart by Sevoflurane: Comparison with Halothane
Anesth. Analg., May 1, 2000; 90(5): 1089 - 1097.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.